Amgen Inc. buy Royal Bank of Canada
Start price
03.04.24
/
50%
€254.85
Target price
03.04.25
€304.82
Performance (%)
1.18%
Price
29.04.24
€257.85
Summary
This prediction is currently active. With a performance of 1.18%, the BUY prediction by Royal_Bank_of_Canada for Amgen Inc. is trending in the right direction. This prediction currently runs until 03.04.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Amgen Inc. | 0.979% |
iShares Core DAX® | 0.961% |
iShares Nasdaq 100 | 2.626% |
iShares Nikkei 225® | 0.217% |
iShares S&P 500 | 1.540% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $329.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat